Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The American Society of Radiologic Technologists (ASRT) has published a new white paper on AI and its potential impact on the work of medical imaging and radiation therapy professionals.
Machine learning (ML) algorithms can be trained to predict acute kidney injury (AKI) in burn and trauma patients within the first 24 hours, according to a new study published in Scientific Reports.
Civica Rx, the startup drug company founded by health foundations, is teaming up with Thermo Fisher Scientific in a seven-year agreement to develop and manufacture medications, with Civica serving as the owner of the regulatory pathway.
Interacting with a computer-animated virtual counselor could help patients know more about complex health issues, including breast cancer, according to new findings published in the Journal of General Internal Medicine.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.